Echocardiographic Assessment of Cardiac Amyloidosis

Speaker: Chi-Ming Chow MD MSc FRCPC FASE FCCS
Director of Echo Lab, St. Michael's Hospital
Professor in Medicine, University of Toronto
Date: June 9, 2022
Objectives:
1) Describe what is amyloid and the cardiac involvement
2) Describe the classic echo features of cardiac amyloid
3) Describe the novel and emerging echo features of cardiac amyloid
4) Describe the artificial intelligence in the assessing cardiac amyloid
Reference:
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
Can J Cardiol. 2020 Mar;36(3):322-334. doi: 10.1016/j.cjca.2019.12.034.